These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 740304)

  • 1. [Fosfomycin in urogenital infections. Experimental assumptions and clinical results].
    Savoia D; Fontana G; Laudi M; Cauda F
    Minerva Med; 1978 Dec; 69(59):4087-91. PubMed ID: 740304
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of metronidazole and fosfomycin alone and in combination in the treatment of experimentally induced intra-abdominal infections.
    Nord CE; Lahnborg G
    Scand J Gastroenterol Suppl; 1984; 90():15-9. PubMed ID: 6588479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fosfomycin. II. Antimicrobial activity in vivo].
    Carlone NA; Cuffini AM; Savoia D
    G Batteriol Virol Immunol; 1977; 70(7-12):215-25. PubMed ID: 615746
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study and use of fosfomycin in the clinical field].
    Azzaroli P; de Martinis E; Zoli F; Garoia C
    G Ital Chemioter; 1978; 25(1):1-4. PubMed ID: 376386
    [No Abstract]   [Full Text] [Related]  

  • 5. Fosfomycin. Controlled clinical studies.
    Rodriguez A; Olay T; Vicente MV; Oliver LE
    G Ital Chemioter; 1977; 23(2):127-32. PubMed ID: 342325
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experiments in the use of fosfomycin in oral microbial infections].
    Quaranta M
    Dent Cadmos; 1983 Mar; 51(3):57-64. PubMed ID: 6576933
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fosfomycin in severe infection in neonatology].
    Rossignol S; Regnier C
    Ann Pediatr (Paris); 1984 May; 31(5):437-44. PubMed ID: 6742722
    [No Abstract]   [Full Text] [Related]  

  • 8. [Nephrological experiences in the treatment of urinary infections by fosfomycin].
    Mioli V; Figus S
    Minerva Med; 1978 Dec; 69(59):4093-6. PubMed ID: 740305
    [No Abstract]   [Full Text] [Related]  

  • 9. Fosfomycin therapy of experimental infections in mice.
    Schindler J; Langsádl L
    Zentralbl Bakteriol Orig A; 1979 Mar; 243(1):136-9. PubMed ID: 375622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter, randomized parallel double-blind study comparing three antibiotics, cephemic-cofosfolactamine, fosfomycin and cephalexin, in the treatment of systemic infections.
    Mangini P; Cicchetti M; Bottaro L; Messina V; Brancadoro MT; Puppo F
    Chemioterapia; 1985 Jun; 4(3):222-6. PubMed ID: 4028283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of fosfomycin in antibiotic therapy. Its effectiveness in patients with acute renal insufficiency or on hemodialysis treatment].
    Rossi R; Colantonio G; Fraticelli M; Giura C; Quarenghi MI; Polli O; Ferradini MA; Nonini MO
    G Ital Chemioter; 1979; 26(1-2):315-7. PubMed ID: 554823
    [No Abstract]   [Full Text] [Related]  

  • 12. Fosfomycin in paediatric cancer patients: a feasible alternative to glycopeptides?
    Hepping N; Simon A
    Int J Antimicrob Agents; 2009 Apr; 33(4):389. PubMed ID: 19097756
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fosfomycin in a hematology department].
    Dinelli CA; Montrasio PL; Tansini G
    Minerva Med; 1978 Dec; 69(59):4111-4. PubMed ID: 740308
    [No Abstract]   [Full Text] [Related]  

  • 14. A review of models for the therapy of experimental infections.
    Bergeron MG
    Scand J Infect Dis Suppl; 1978; (14):189-206. PubMed ID: 279972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of cofosfolactamine in localized bacterial infections].
    Scalzini A; Chiodera A; Sueri L
    G Ital Chemioter; 1984; 31(1-2):205-6. PubMed ID: 6468828
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical use of fosfomycin in bacterial infections of the oral cavity in childhood].
    Ghezzi F; Zallio F
    Minerva Stomatol; 1985; 34(4):703-6. PubMed ID: 3862951
    [No Abstract]   [Full Text] [Related]  

  • 17. [The protective effect of phosphonic compounds (sodium-fosfomycin and arginine-fosfomycin) in experimental infections in the mouse].
    Martinetto P; Valtz A; Angeretti A; Gaffodio AM; Negro Ponzi A
    G Ital Chemioter; 1979; 26(1-2):223-6. PubMed ID: 554813
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of fosfomycin in the most frequently recurring pediatric infections].
    Minerva Med; 1978 Dec; 69(59):4129-34. PubMed ID: 740311
    [No Abstract]   [Full Text] [Related]  

  • 19. [Phosphomycin for the prevention of bacterial infections in high risk patients].
    Faedda R; Tocco A; Vacca R; Deplano A; Olmeo NA; Branca FG; Bartoli E
    Clin Ter; 1981 Nov; 99(3):295-304. PubMed ID: 7307457
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental endocarditis and fosfomycin.
    Rodríguez A; Vicente MV; Olay T
    Drugs Exp Clin Res; 1985; 11(1):55-62. PubMed ID: 3836112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.